Interní Med. 2010; 12(1): 18-21
Patients with chronic kidney disease (CKD) are more threatened by drug adverse effects and interactions. Pathophysiological changes
caused by CKD influence many pharmacokinetics properties, resulting in diminished glomerural filtration rate (GF) and altered tubular
secretion and reabsorbtion. Before setting a patient on a new drug, next scheme is recommended: estimating renal functions (preferably
creatinine clearance), evaluation of drug clearance and estimating initial and maintenance dose, checking of plasma level, and
dose revision, if appropriate. In renal-excreted drugs, dosing scheme may be adjusted by dose reducing, interval prolongation or both.
Choosing a suitable drug in dialysed patients is a common problem. It is neccessary to consider binding to plasma albumin, molecular
weight as well as many further aspects, e.g. determined by anuria and consequent need of water restriction. Selection of a suitable drug
and adequate dosing is essential for preventing adverse effects and obtaining optimal therapeutic effect.
Published: May 1, 2010 Show citation